Literature DB >> 15639116

Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders.

C Y Yu Wai Man1, P F Chinnery, P G Griffiths.   

Abstract

While skeletal muscles generally perform specific limited roles, extraocular muscles (EOMs) have to be responsive over a wider dynamic range. As a result, EOMs have fundamentally distinct structural, functional, biochemical and immunological properties compared to other skeletal muscles. While these properties enable high fatigue resistance and the rapid and precise control of extraocular motility, they might also explain why EOMs are selectively involved in certain disorders, such as chronic progressive external ophthalmoplegia (CPEO), myasthenia gravis and Graves' ophthalmopathy. This review first gives an overview of the novel myofibre classification in EOMs and then focuses on those properties that might explain why ophthalmoplegia should be so prominent in these disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15639116     DOI: 10.1016/j.nmd.2004.10.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  21 in total

Review 1.  Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathy.

Authors:  Wilmar M Wiersinga; Noortje I Regensburg; Maarten P Mourits
Journal:  Eur Thyroid J       Date:  2013-02-26

2.  Extraocular muscle satellite cells are high performance myo-engines retaining efficient regenerative capacity in dystrophin deficiency.

Authors:  Pascal Stuelsatz; Andrew Shearer; Yunfei Li; Lindsey A Muir; Nicholas Ieronimakis; Qingwu W Shen; Irina Kirillova; Zipora Yablonka-Reuveni
Journal:  Dev Biol       Date:  2014-09-16       Impact factor: 3.582

3.  Development of extraocular muscles requires early signals from periocular neural crest and the developing eye.

Authors:  Brenda L Bohnsack; Donika Gallina; Hannah Thompson; Daniel S Kasprick; Mark J Lucarelli; Gregory Dootz; Christine Nelson; Imelda M McGonnell; Alon Kahana
Journal:  Arch Ophthalmol       Date:  2011-04-11

4.  Bilateral Ocular Myositis Associated with Whipple's Disease.

Authors:  Vivak Parkash; Hardeep Singh Mudhar; Bart E Wagner; Didier Raoult; Ruth Batty; Hubert Lepidi; John Burke; Paul Collini; Thushan de Silva
Journal:  Ocul Oncol Pathol       Date:  2016-09-07

5.  A reinterpretation of certain disorders affecting the eye muscles and their tissues.

Authors:  Anuchit Poonyathalang; Sangeeta Khanna; R John Leigh
Journal:  Clin Ophthalmol       Date:  2007-12

6.  Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement.

Authors:  Laura Cucurachi; Luigi Cattaneo; Franco Gemignani; Giovanni Pavesi
Journal:  Neurol Sci       Date:  2009-05-30       Impact factor: 3.307

Review 7.  How can we treat mitochondrial encephalomyopathies? Approaches to therapy.

Authors:  Rita Horvath; Grainne Gorman; Patrick F Chinnery
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

8.  Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.

Authors:  Giovanna Cenacchi; Valentina Papa; Papa Valentina; Marina Fanin; Fanin Marina; Elena Pegoraro; Pegoraro Elena; Corrado Angelini; Angelini Corrado
Journal:  J Neurol       Date:  2010-11-19       Impact factor: 4.849

9.  Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles.

Authors:  Patrick Yu-Wai-Man; Joey Lai-Cheong; Gillian M Borthwick; Langping He; Geoffrey A Taylor; Laura C Greaves; Robert W Taylor; Philip G Griffiths; Douglass M Turnbull
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

Review 10.  The mitochondrial brain: From mitochondrial genome to neurodegeneration.

Authors:  Helen E Turnbull; Nichola Z Lax; Daria Diodato; Olaf Ansorge; Doug M Turnbull
Journal:  Biochim Biophys Acta       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.